The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso ... commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for ...

That’s basically what the community-made PolyDye project does, which adds an inkjet cartridge to an existing FDM printer. In the [Teaching Tech] video the PolyDye technology is demonstrated ...

Since the mid-1800s, there have been dozens of rifle and revolver cartridges chambered for lever-action rifles. Most have come and gone without much fanfare, but a handful changed the game.

There’s only a handful of authentically dangerous game out there, which is why rifles and cartridges for some are not sold in every gun store. But these critters deserve to be taken seriously.

Tired of constantly replacing ink cartridges? The best ink tank printers offer a more economical way to print at high volumes. By releasing you from a commitment to cartridge ink, refillable ink ...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA ® (elexacaftor ...

Please provide your email address to receive an email when new articles are posted on . Percent-predicted FEV 1, sweat chloride and safety were analyzed in two phase 3 trials of vanzacaftor ...

As Vertex Pharmaceuticals reels from a painful trial readout for its pain candidate suzetrigine, the Boston biotech has chalked up a win in its specialty area of cystic fibrosis. The FDA has ...

Participants were randomly assigned to receive Trikafta or placebo based on age and weight: Aged 6 to <12 years and less than 30kg: morning dose of elexacaftor 100mg/tezacaftor 50mg/ivacaftor 75mg ...

It will be marketed as Alyftrek. Vertex also won expanded approval for Trikafta, which was first approved in 2019. Trikafta has become Vertex’s (Nasdaq: VRTX) blockbuster CF drug, helping drive ...

TRIKAFTA, a combination of elexacaftor, tezacaftor, and ivacaftor, is designed to enhance the function of the defective protein caused by cystic fibrosis transmembrane conductance regulator (CFTR ...